对于进入降压市场的新药而言情况十分残酷，因为目前已有成本近乎为零的好药。
It is tough for a new drug to enter the blood pressure lowering market mainly because we have such good drugs which cost next to nothing.
对于进入降压市场的新药而言情况十分残酷，因为目前已有成本近乎为零的好药。
It is tough for a new drug to enter the blood pressure lowering market mainly because we have such good drugs which cost next to nothing.
应用推荐